Literature DB >> 3498646

The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections.

W R Jarvis1, D Olson, O Tablan, W J Martone.   

Abstract

Pseudomonas cepacia has recently emerged as an important nosocomial pathogen. We analyzed a national nosocomial infections database, the National Nosocomial Infections Surveillance (NNIS) system, to describe the epidemiology of endemic nosocomial P. cepacia infections. Between 1980 and 1985, the P. cepacia nosocomial infection rate was 2.4 per 100,000 patient discharges. During this period, there was a significant increase in the P. cepacia infection rate. The highest infection rate was reported from large medical school-affiliated hospitals. Over 90% of the infections were reported from medicine and surgery services. The most frequently reported site of infection was the lower respiratory tract (31%), followed by blood (20%) and the urinary tract (20%). Nosocomial P. cepacia infections are often associated with mortality, particularly when they involve the lung. These data confirm the hypothesis that P. cepacia is an emerging nosocomial pathogen and suggest that the epidemiology of endemic infections differs from that reported for epidemic infections.

Entities:  

Mesh:

Year:  1987        PMID: 3498646     DOI: 10.1007/BF00149729

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  5 in total

1.  Infection control in pulmonary function laboratories.

Authors:  O C Tablan; W W Williams; W J Martone
Journal:  Infect Control       Date:  1985-11

Review 2.  The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Authors:  W J Martone; O C Tablan; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

3.  Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.

Authors:  O C Tablan; W J Martone; C F Doershuk; R C Stern; M J Thomassen; J D Klinger; J W White; L A Carson; W R Jarvis
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

4.  Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Authors:  O C Tablan; T L Chorba; D V Schidlow; J W White; K A Hardy; P H Gilligan; W M Morgan; L A Carson; W J Martone; J M Jason
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

5.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

  5 in total
  8 in total

1.  Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes.

Authors:  M L Hutchison; I R Poxton; J R Govan
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 2.  Current status of Pseudomonas cepacia typing systems.

Authors:  C S Rabkin; W R Jarvis; W J Martone
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

Review 3.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

4.  Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak.

Authors:  C F Pegues; D A Pegues; D S Ford; P L Hibberd; L A Carson; C M Raine; D C Hooper
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

Review 5.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

6.  Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

7.  Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo.

Authors:  Tracey A Hunt; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 8.  Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

Authors:  A Holmes; J Govan; R Goldstein
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.